about
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab...
Read More
33.85
-1.49
(-4.22%)
2.0M
XNAS Volume
XNAS 15 Jan, 2026 4:30 PM (EST)
High Financial Strength
Mid Valuation
Technically Bullish
Strong Performer, Getting Expensive
These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying
View Similar
Embed DVM
Genmab (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..